Vanguard Personalized Indexing Management LLC Increases Stock Position in Agilent Technologies, Inc. $A

Key Points

• Vanguard Personalized Indexing Management LLC increased its stake in Agilent Technologies by 37.6% in Q2, now owning 38,660 shares valued at $4.56 million.
• Agilent Technologies reported quarterly earnings of $1.37 EPS, meeting analyst expectations, with revenue of $1.74 billion, exceeding forecasts of $1.67 billion.
• The company recently announced a quarterly dividend of $0.248 per share, with an annualized yield of 0.7%, and a dividend payout ratio of 23.24%.

Vanguard Personalized Indexing Management LLC boosted its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 37.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 38,660 shares of the medical research company's stock after acquiring an additional 10,567 shares during the period. Vanguard Personalized Indexing Management LLC's holdings in Agilent Technologies were worth $4,562,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of A. Brighton Jones LLC lifted its position in Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock valued at $626,000 after acquiring an additional 270 shares during the last quarter. GAMMA Investing LLC lifted its position in Agilent Technologies by 34.6% in the first quarter. GAMMA Investing LLC now owns 5,362 shares of the medical research company's stock valued at $627,000 after acquiring an additional 1,379 shares during the last quarter. Assenagon Asset Management S.A. lifted its position in Agilent Technologies by 8.3% in the first quarter. Assenagon Asset Management S.A. now owns 30,827 shares of the medical research company's stock valued at $3,606,000 after acquiring an additional 2,371 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in Agilent Technologies by 86.3% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 51,363 shares of the medical research company's stock valued at $6,009,000 after acquiring an additional 23,800 shares during the last quarter. Finally, Opal Wealth Advisors LLC purchased a new stake in Agilent Technologies in the first quarter valued at $31,000.

Agilent Technologies Trading Up 1.3%

NYSE A opened at $138.43 on Tuesday. The stock has a market capitalization of $39.24 billion, a P/E ratio of 32.49, a P/E/G ratio of 4.46 and a beta of 1.26. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84. The firm has a 50-day moving average price of $125.51 and a 200 day moving average price of $117.17. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm's revenue for the quarter was up 10.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be issued a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies's dividend payout ratio (DPR) is 23.24%.

Analyst Ratings Changes

A number of brokerages have recently commented on A. Evercore ISI upped their target price on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an "in-line" rating in a report on Tuesday, October 7th. Rothschild Redb raised shares of Agilent Technologies to a "strong-buy" rating in a report on Wednesday, October 8th. Wells Fargo & Company upped their target price on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an "overweight" rating in a report on Monday, September 15th. Robert W. Baird upped their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an "outperform" rating in a report on Thursday, August 28th. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Agilent Technologies in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $148.69.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.